Related Experiment Video
Updated: Sep 11, 2025
Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
Published on: June 24, 2019
Assessment of Eotaxin Concentration in Children with Chronic Kidney Disease
Marta Badeńska1, Andrzej Badeński1, Elżbieta Świętochowska2
1Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.
Insights
Elevated eotaxin levels in both serum and urine may indicate chronic kidney disease (CKD) in children. This finding suggests eotaxin could be a potential biomarker for early pediatric CKD diagnosis.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Immunology
Background:
- Chronic kidney disease (CKD) significantly impacts pediatric morbidity and mortality.
- Early diagnosis and management are crucial for slowing CKD progression.
- Eotaxin's role in pediatric kidney disease is not well-established.
Purpose of the Study:
- To assess serum and urine eotaxin concentrations in children with CKD.
- To evaluate correlations between eotaxin levels and biochemical markers.
- To determine eotaxin's potential as a diagnostic marker for pediatric CKD.
Main Methods:
- Measurement of serum and urine eotaxin levels in pediatric CKD patients and healthy controls.
- Analysis of correlations with clinical and biochemical parameters.
- Utilizing Receiver Operating Characteristic (ROC) curves for diagnostic accuracy assessment.
Main Results:
- Significantly higher serum and urine eotaxin concentrations were observed in children with CKD compared to controls.
- Eotaxin levels showed high sensitivity and specificity in differentiating CKD patients from healthy individuals.
- Potential correlations with selected biochemical markers were explored.
Conclusions:
- Eotaxin may serve as a valuable biomarker for detecting CKD in the pediatric population.
- Further research is warranted to validate eotaxin's utility in clinical practice.
- This study highlights a novel approach to pediatric CKD diagnostics.
Abstract:
Chronic kidney disease (CKD) is a progressive condition which still leads to significant morbidity and mortality among patients at all ages. Its proper management should be focused on slowing down the disease sequelae, as well as establishing an early diagnosis and treatment of its complications. Eotaxin is a potent, selective eosinophil chemoattractant, which is reported to have an impact on various kidney diseases. Nevertheless, data regarding the potential correlation between eotaxin and CKD in a pediatric population is still scarce. This study aims to assess the concentration of eotaxin in children with CKD and evaluate potential correlations with selected biochemical markers and disease occurrence. Both serum and urine eotaxin concentrations were markedly higher in children with CKD compared to healthy controls. Moreover, Receiver Operating Characteristic (ROC) curves have shown that serum eotaxin and urine eotaxin levels demonstrated high sensitivity and high specificity for the allocation of patients to the study and control groups. The authors advanced a thesis that eotaxin might serve as a marker of CKD occurrence in a pediatric population. Such a research design is innovative, since it has not been analyzed in the literature yet. However, further studies are required.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:28Chronic Kidney Disease III: Interprofessional Care
01:18Chronic Kidney Disease IV: Nursing Management
01:24Chronic Kidney Disease II: Clinical Manifestations
01:29Acute Kidney Injury III: Clinical Manifestations
01:22Acute Kidney Injury I: Introduction